Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
2009 StandoutScienceNobel
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
2013
Improved survival of children and adolescents with sickle cell disease
2010
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Factors associated with lowered intelligence in homozygous sickle cell disease.
1995
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010 Standout
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab
2008
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Sickle Cell Disease in Africa
2011
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
2009 StandoutNobel
Trade‐offs in evolutionary immunology: just what is the cost of immunity?
2000 Standout
Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment
2015
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
2016 StandoutNobel
mRNA as novel technology for passive immunotherapy
2018
The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
2008 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
2008
Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation
2012
Molecular mechanism and function of CD40/CD40L engagement in the immune system
2009
Healthcare utilization and expenditures for low income children with sickle cell disease
2008
Newborn screening for sickle cell disease in the Republic of Benin
2008
Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case–control study
2009
Neonatal/newborn haemoglobinopathy screening in Europe and Africa
2008
Haematopoietic cell transplantation in the treatment of sickle cell disease
2003
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Bioequivalence and the immunogenicity of biopharmaceuticals
2002
Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: Lessons from pilot studies
2008
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
Monoclonal antibodies: versatile platforms for cancer immunotherapy
2010
A novel role for 12/15-lipoxygenase in regulating autophagy
2014 StandoutNobel
Control of Germinal Center Responses by T-Follicular Regulatory Cells
2018 StandoutNobel
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
2010
Toxicity of cationic lipids and cationic polymers in gene delivery
2006 Standout
Follicular B helper T cells in antibody responses and autoimmunity
2005
Functions of natural killer cells
2008 Standout
Genetic medicines: treatment strategies for hereditary disorders
2006
Antibody therapy of cancer
2012 Standout
Global Burden of Sickle Cell Anaemia in Children under Five, 2010–2050: Modelling Based on Demographics, Excess Mortality, and Interventions
2013
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Controlled release systems for DNA delivery
2004
Non-viral vectors for gene-based therapy
2014 Standout
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Outcome of Sickle Cell Anemia
2005
Targeting apoptosis in cancer therapy
2020 Standout
Newborn Sickle Cell Screening in a Region of Western New York State
2008
Graft-versus-host disease
2009 Standout
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Gene therapy for hemophilia
2015
Impact of a Comprehensive Sickle Cell Center on Early Childhood Mortality in a Developing Country: The Jamaican Experience
2015
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Activation, coactivation, and costimulation of resting human natural killer cells
2006
Engineering Factor Viii for Hemophilia Gene Therapy
2012
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Gene therapy for mucopolysaccharidosis
2007
Sickle-cell disease
2010 Standout
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
2011
Prospects for the use of NK cells in immunotherapy of human cancer
2007
Fortnightly Review: Neonatal screening for sickle cell disorders: what about the carrier infants?
1996
Adeno-associated viral vectors for the treatment of hemophilia
2015
Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
2015
IgG4-related disease
2014 Standout
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
2015
The PI3K Pathway in Human Disease
2017 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Comparison of homozygous sickle cell disease in Northern Greece and Jamaica
1990
Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma
2019
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm
2006 Standout
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
2014 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy
2016 StandoutNobel
Synthesis and Function of 3-Phosphorylated Inositol Lipids
2001 Standout
Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease
1998
Detection of EPO gene doping in blood
2012
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
2005
Follicular Helper CD4 T Cells (TFH)
2011 Standout
IL-17 and Th17 Cells
2009 Standout
BCR signaling inhibitors differ in their ability to overcome Mcl-1–mediated resistance of CLL B cells to ABT-199
2016
Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting
2003
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Lung volumes and forced ventilatory flows
1993 Standout
Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure
2000
Survival of children with sickle cell disease
2004
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Human natural killer cells
2008
Sickle cell disease related mortality in the United States (1999-2009)
2013
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure
2000
Newborn screening program for hemoglobinopathies in Rio de Janeiro, Brazil
2013
Eosinophilia in Southeast Asian Refugees: Evaluation at a Referral Center
1987
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Acceleration in linear growth after splenectomy for hypersplenism in homozygous sickle cell disease.
1995
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Reference values and prediction equations for normal lung function in a non-smoking white urban population.
1991
Works of Deborah Hurst being referenced
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia
2015
Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma
2014
Lung function in the elderly.
1985
A Phase 1 Dose Escalation Study of a Fully Human, Antagonist Anti-CD40 Antibody, HCD122 (Formerly CHIR-12.12) in Patients with Relapsed and Refractory Multiple Myeloma.
2006
GROWTH RETARDATION IN SICKLE-CELL DISEASE TREATED BY NUTRITIONAL SUPPORT
1985
Pharmacokinetics and Pharmacodynamics from a First-in-Human Phase 1 Dose Escalation Study with Antagonist Anti-CD40 Antibody, HCD122 (Formerly CHIR-12.12), in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia.
2006
Newborn Screening for Sickle Cell Disease: Effect on Mortality
1989
Newborn Screening for Sickle Cell Disease: Effect on Mortality
1988
Northern California's Experience
1989
Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma
2004
A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma
2006
The Inhibitor Antibody Response Is More Complex in Hemophilia A Patients Than in Most Nonhemophiliacs With Factor VIII Autoantibodies
1997
Anemia and hemoglobinopathies in Southeast Asian refugee children
1983
Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion
2003